Autoplaque vs Rapid PE Triage and Notification (PETN)
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a detailed, quantitative assessment of coronary artery plaque burden and luminal stenosis from CT angiography images. This tool is ideal for clinicians focused on comprehensive cardiovascular risk stratification and guiding long-term treatment strategies for atherosclerotic disease.
View Autoplaque →Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification (PETN) if your priority is the rapid identification and immediate notification of suspected central pulmonary embolisms from CTPA scans. This solution is best suited for emergency departments and critical care settings where timely detection and accelerated care pathways for acute, life-threatening conditions are paramount.
View Rapid PE Triage and Notification (PETN) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid PE Triage and Notification (PETN)Tool B, Rapid PE Triage and Notification, offers real-time notifications across multiple platforms including PACS, email, and mobile apps, emphasizing broad and immediate accessibility for its triage function. In contrast, Tool A, Autoplaque, is workstation-based, suggesting a more dedicated setup for detailed interactive analysis rather than rapid, widespread notification.
Clinical Value
TieBoth tools are FDA-cleared and address critical, life-threatening conditions with high clinical impact. Autoplaque provides quantitative analysis for heart attack risk prediction and treatment guidance, while Rapid PE Triage and Notification accelerates care pathways for acute pulmonary embolisms. Both offer significant value in their respective specialized domains.
Pricing & Value
TieNeither Autoplaque nor Rapid PE Triage and Notification publicly disclose their pricing information. Both are likely enterprise-level solutions, making a direct comparison of their value proposition based on cost impossible without further details.
Enterprise Readiness
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with flexible deployment options (on-premise or cloud). Autoplaque, being workstation-based, does not specify HIPAA compliance or BAA in the provided information, giving Tool B a clear advantage in enterprise readiness.
Innovation
AutoplaqueAutoplaque demonstrates significant innovation through its AI-powered quantitative analysis of coronary plaque morphology and luminal stenoses, providing detailed, editable segmentations for heart attack risk prediction. While Rapid PE Triage and Notification offers innovative rapid detection and workflow integration for acute PE, Autoplaque's depth of quantitative analysis for a complex diagnostic task represents a more profound advancement in imaging analysis.
Support & Docs
Rapid PE Triage and Notification (PETN)RapidAI, the developer of Rapid PE Triage and Notification, is a dedicated commercial entity known for offering 24/7 customer support, comprehensive training, and documentation. In contrast, Autoplaque is developed by a medical center's research arm, and explicit information regarding commercial support channels or public documentation is not readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Purpose | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Rapidly identify and notify clinicians of suspected central pulmonary embolisms from CTPA images, streamlining workflow and accelerating patient care pathways. |
| Company | Cedars-Sinai Medical Center: AIM | RapidAI (formerly iSchemaView) |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Radiology |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | AI/ML module for CTPA image analysis; Detection of suspected central pulmonary embolism (PE); Workflow triage and prioritization; Real-time notifications to clinicians (PACS, email, mobile app); Compressed preview images (not for diagnostic use); Operates in parallel with standard of care; Integration within the Rapid Platform; Mobile and desktop application access |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Rapid PE Triage and Notification (PETN).